Strunin L, Strunin J M, Knights K M, Ward M E
Br J Anaesth. 1977 Jun;49(6):609-14. doi: 10.1093/bja/49.6.609.
The metabolism of 14C-labelled alphaxalone, dispensed as Althesin, was studied in normal patients, patients with obstructive jaundice and patients with chronic renal disease and anuria. The radioactive label was removed rapidly from the plasma following i.v. administration. The major portion of the label was excreted in the urine. In patients with normal renal function 14C-labelled alphaxalone is probably taken up by the liver, metabolized to a more polar compound and excreted in the urine; a small amount is excreted in the bile. In the patient with anuria, hepatic uptake appears to be relatively normal and the length of action of Althesin is not prolonged. It is assumed that in such patients the eventual route of excretion is via the bile and faeces.
以阿尔忒辛(Althesin)形式给药的14C标记alphaxalone在正常患者、梗阻性黄疸患者以及慢性肾病和无尿患者中的代谢情况进行了研究。静脉注射给药后,放射性标记物迅速从血浆中清除。大部分标记物经尿液排出。在肾功能正常的患者中,14C标记的alphaxalone可能被肝脏摄取,代谢为极性更强的化合物后经尿液排出;少量经胆汁排出。在无尿患者中,肝脏摄取似乎相对正常,阿尔忒辛的作用时长未延长。据推测,在此类患者中,最终的排泄途径是通过胆汁和粪便。